HUP0302295A2 - Tienodibenzoazulén-származékok, eljárás előállításukra, alkalmazásuk - Google Patents
Tienodibenzoazulén-származékok, eljárás előállításukra, alkalmazásukInfo
- Publication number
- HUP0302295A2 HUP0302295A2 HU0302295A HUP0302295A HUP0302295A2 HU P0302295 A2 HUP0302295 A2 HU P0302295A2 HU 0302295 A HU0302295 A HU 0302295A HU P0302295 A HUP0302295 A HU P0302295A HU P0302295 A2 HUP0302295 A2 HU P0302295A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- general formula
- alkyl
- carbon
- derivatives
- Prior art date
Links
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 2
- -1 cyano- Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004970 halomethyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
A találmány (I) általános képletű dibenzoazulén-származékokra,gyógyászatilag elfogadható sóira vagy szolvátjaira vonatkozik. Az (I)általános képletben X jelentése metiléncsoport vagy heteroatom,például oxigén- vagy kénatom, -S(O)- vagy -S(O)2 képletű csoport vagy-N(R13)- általános képletű csoport, ahol R13 jelentése hidrogénatom,1-6 szénatomos alkil-, 1-6 szénatomos alkilkarbonil-, arilkarbonil-,1-6 szénatomos alkilszulfonil- vagy arilszulfonil-csoport és R1, R2,R3, R4, R5, R6, R7, R8 és R9 jelentése hidrogén- vagy halogénatom;vagy 1-7 szénatomos alkil-, alkenil-, aril- vagy heteroarilcsoport;vagy különböző csoportok, mégpedig halogénmetil-, hidroxil-, 1-7szénatomos alkoxi- vagy ariloxicsoport, 1-7 szénatomos alkitio- vagyariltiocsoport, 1-7 szénatomos alkilszulfonil-, ciano-, amino-, mono-vagy di(1-7 szénatomos)-(szubsztituált amin) vagy akarboxilcsoportszármazékai; vagy 1-7 szénatomos karbonilszármazékok;és R10 jelentése 2-15 szénatomos alkil-, 2-15 szénatomos alkenil-, 2-15 szénatomos alkinil-, aril- vagy heteroarilcsoport, 1-15 szénatomoshalogénalkil-, 1-15 szénatomos hidroxialkil-, 1-15 szénatomosalkiloxi-, 1-15 szénatomos alkiltio-, 3-15 szénatomos alkilkarbonil-,2-15 szénatomos alkilkarbonsav-, 2-15 szénatomos alkil-észter-, 1-15szénatomos alkilszulfonil-, 1-15 szénatomos alkilaril-szulfonil- vagyarilszulfonilcsoport vagy -(CH2)n-A általános képletű 1-15 szénatomosalkil-amin, ahol n jelentése 1-15 és egy vagy több metiléncsoportoxigén- vagy kénatommal lehet helyettesítve és A jelentése 5- vagy 6-tagú telített vagy telítetlen gyűrű, amely 1-3 heteroatomot tartalmazvagy -N(R11, R12) általános képletű csoport, ahol R11 és R12 jelentésehidrogénatom, 1-7 szénatomos alkil-, alkenil-, alkinil-, aril- vagyheteroarilcsoport vagy 1-3 heteroatomot tartalmazó heterociklusoscsoport. A találmány kiterjed az (I) általáros képletű vegyületekelőállítására és citokinek vagy gyulladásközvetítők túlzott ésszabályozatlan termelődése által okozott állapotok és betegségekkezelésére vagy megelőzésére történő alkalmazására Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR20000310A HRP20000310A2 (en) | 2000-05-17 | 2000-05-17 | New dibenzoazulene compounds as tumor necrosis factor inhibitors |
PCT/HR2001/000027 WO2001087890A1 (en) | 2000-05-17 | 2001-05-16 | Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0302295A2 true HUP0302295A2 (hu) | 2003-10-28 |
HUP0302295A3 HUP0302295A3 (en) | 2007-03-28 |
Family
ID=10947110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302295A HUP0302295A3 (en) | 2000-05-17 | 2001-05-16 | Thienodibenzoazulene derivatives, process for their preparation and use thereof |
Country Status (37)
Country | Link |
---|---|
US (2) | US6897211B2 (hu) |
EP (1) | EP1284977B1 (hu) |
JP (1) | JP2003533528A (hu) |
KR (1) | KR100823064B1 (hu) |
CN (1) | CN1194976C (hu) |
AR (1) | AR030562A1 (hu) |
AT (1) | ATE434619T1 (hu) |
AU (2) | AU2001256560B2 (hu) |
BG (1) | BG65967B1 (hu) |
BR (1) | BR0111202A (hu) |
CA (1) | CA2409090C (hu) |
CR (1) | CR6860A (hu) |
CY (1) | CY1109328T1 (hu) |
CZ (1) | CZ301770B6 (hu) |
DE (1) | DE60139070D1 (hu) |
DK (1) | DK1284977T3 (hu) |
DZ (1) | DZ3357A1 (hu) |
EA (1) | EA006069B1 (hu) |
EE (1) | EE200200636A (hu) |
ES (1) | ES2328335T3 (hu) |
GE (1) | GEP20043304B (hu) |
HK (1) | HK1056719A1 (hu) |
HR (1) | HRP20000310A2 (hu) |
HU (1) | HUP0302295A3 (hu) |
IL (1) | IL152809A0 (hu) |
IS (1) | IS6621A (hu) |
MA (1) | MA27125A1 (hu) |
MX (1) | MXPA02011269A (hu) |
NO (1) | NO20025510L (hu) |
NZ (1) | NZ522553A (hu) |
PL (1) | PL204849B1 (hu) |
PT (1) | PT1284977E (hu) |
RS (1) | RS50893B (hu) |
SI (1) | SI1284977T1 (hu) |
SK (1) | SK17702002A3 (hu) |
WO (1) | WO2001087890A1 (hu) |
ZA (1) | ZA200209180B (hu) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20020305A8 (en) * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
HRP20020303B8 (en) * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
HRP20020304B1 (en) | 2002-04-10 | 2008-04-30 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof |
HRP20020440B1 (en) | 2002-05-21 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
HRP20020441A2 (en) * | 2002-05-21 | 2003-12-31 | Pliva D D | 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
HRP20020453A2 (en) | 2002-05-23 | 2003-12-31 | Pliva D D | 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
HRP20020452A2 (en) | 2002-05-23 | 2004-02-29 | Pliva D D | 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof |
HRP20020451A2 (en) * | 2002-05-23 | 2003-12-31 | Pliva D D | 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof |
HRP20030160A2 (en) * | 2003-03-06 | 2005-04-30 | Pliva-Istra�iva�ki institut d.o.o. | 1-thiadibenzoazulene derivatives and biological action thereof |
HRP20030324A2 (en) | 2003-04-24 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | Compounds of antiinflammatory effect |
US20090018351A1 (en) * | 2003-11-12 | 2009-01-15 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
HRP20030955A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20030954A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva D.D. | USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
HRP20040104A2 (en) * | 2004-01-30 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
ES2337915T3 (es) | 2004-10-27 | 2010-04-30 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Conjugados con adtividad antiinflamatoria. |
CA2588760C (en) * | 2004-12-07 | 2014-05-13 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
US20080096830A1 (en) * | 2005-01-13 | 2008-04-24 | Mladen Mercep | Anti-Inflammatory Macrolide Conjugates |
AU2007223787A1 (en) | 2006-03-08 | 2007-09-13 | Pharmena North America Inc. | Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuries |
EP2114427B1 (en) | 2007-01-30 | 2014-06-25 | New York University | Peptides for treatment of conditions associated with nitric oxide |
WO2008096755A1 (ja) * | 2007-02-07 | 2008-08-14 | Nippon Suisan Kaisha, Ltd. | バニロイド受容体(vr1)阻害剤及びその用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711489A (en) * | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
JPS53116385A (en) * | 1977-03-19 | 1978-10-11 | Hokuriku Pharmaceutical | Pyrazin derivative and method for its production |
US4198421A (en) * | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
SI0892793T1 (en) * | 1996-04-12 | 2003-10-31 | Janssen Pharmaceutica N.V. | Substituted tetracyclic tetrahydrofuran derivatives |
GB9713368D0 (en) * | 1997-06-25 | 1997-08-27 | Weston Medical Ltd | Flame control |
EP0887339A1 (de) * | 1997-06-27 | 1998-12-30 | Roche Diagnostics GmbH | Neue Azulenderivate und diese enthaltende Arzneimittel |
-
2000
- 2000-05-17 HR HR20000310A patent/HRP20000310A2/hr not_active Application Discontinuation
-
2001
- 2001-05-16 SK SK1770-2002A patent/SK17702002A3/sk unknown
- 2001-05-16 PT PT01929882T patent/PT1284977E/pt unknown
- 2001-05-16 CN CNB018115896A patent/CN1194976C/zh not_active Expired - Fee Related
- 2001-05-16 EA EA200201223A patent/EA006069B1/ru not_active IP Right Cessation
- 2001-05-16 EE EEP200200636A patent/EE200200636A/xx unknown
- 2001-05-16 GE GE5019A patent/GEP20043304B/en unknown
- 2001-05-16 ES ES01929882T patent/ES2328335T3/es not_active Expired - Lifetime
- 2001-05-16 SI SI200130930T patent/SI1284977T1/sl unknown
- 2001-05-16 RS YUP-841/02A patent/RS50893B/sr unknown
- 2001-05-16 DZ DZ013357A patent/DZ3357A1/fr active
- 2001-05-16 BR BR0111202-3A patent/BR0111202A/pt not_active Application Discontinuation
- 2001-05-16 NZ NZ522553A patent/NZ522553A/en unknown
- 2001-05-16 DE DE60139070T patent/DE60139070D1/de not_active Expired - Lifetime
- 2001-05-16 IL IL15280901A patent/IL152809A0/xx unknown
- 2001-05-16 HU HU0302295A patent/HUP0302295A3/hu unknown
- 2001-05-16 CA CA2409090A patent/CA2409090C/en not_active Expired - Fee Related
- 2001-05-16 WO PCT/HR2001/000027 patent/WO2001087890A1/en active IP Right Grant
- 2001-05-16 MX MXPA02011269A patent/MXPA02011269A/es active IP Right Grant
- 2001-05-16 AU AU2001256560A patent/AU2001256560B2/en not_active Ceased
- 2001-05-16 PL PL365054A patent/PL204849B1/pl not_active IP Right Cessation
- 2001-05-16 AU AU5656001A patent/AU5656001A/xx active Pending
- 2001-05-16 JP JP2001584284A patent/JP2003533528A/ja active Pending
- 2001-05-16 DK DK01929882T patent/DK1284977T3/da active
- 2001-05-16 AT AT01929882T patent/ATE434619T1/de not_active IP Right Cessation
- 2001-05-16 KR KR1020027015567A patent/KR100823064B1/ko not_active IP Right Cessation
- 2001-05-16 EP EP01929882A patent/EP1284977B1/en not_active Expired - Lifetime
- 2001-05-16 CZ CZ20024090A patent/CZ301770B6/cs not_active IP Right Cessation
- 2001-05-17 AR ARP010102339A patent/AR030562A1/es active IP Right Grant
-
2002
- 2002-11-11 MA MA26901A patent/MA27125A1/fr unknown
- 2002-11-12 ZA ZA200209180A patent/ZA200209180B/en unknown
- 2002-11-14 IS IS6621A patent/IS6621A/is unknown
- 2002-11-15 NO NO20025510A patent/NO20025510L/no not_active Application Discontinuation
- 2002-11-18 US US10/298,217 patent/US6897211B2/en not_active Expired - Fee Related
- 2002-12-17 CR CR6860A patent/CR6860A/es not_active Application Discontinuation
- 2002-12-17 BG BG107399A patent/BG65967B1/bg unknown
-
2003
- 2003-12-11 HK HK03109004A patent/HK1056719A1/xx not_active IP Right Cessation
-
2005
- 2005-03-25 US US11/090,743 patent/US20050171091A1/en not_active Abandoned
-
2009
- 2009-08-20 CY CY20091100888T patent/CY1109328T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302295A2 (hu) | Tienodibenzoazulén-származékok, eljárás előállításukra, alkalmazásuk | |
HUP9602932A2 (hu) | Helyettesített imidazolidin-2,4-dion-vegyületek, felhasználásuk gyógyászati hatóanyagokként és eljárás előállításukra | |
PE20021004A1 (es) | Derivados de piperidina como inhibidores de la ccr5 | |
MXPA01004854A (es) | Nuevos compuestos de piperazina y piperidina. | |
DE69513383D1 (de) | Substituierte 3-arylidinene-7-azaoxindol verbindungen und verfahren zu ihrer herstellung | |
YU46497B (sh) | Postupak za dobijanje novih derivata pirazola | |
HUP0203897A2 (hu) | VLA-4-től függő sejtadhéziót gátló nempeptid inhibitor vegyületek, valamint ezeket tartalmazó gyógyászati készítmények gyulladásos-, autoimmun- és légzőszervi betegségek kezelésére | |
HUP0201935A2 (hu) | A SYK tirozin-protein-kináz inhibitoraiként alkalmazható purinszármazékok | |
HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
HUP9800555A2 (hu) | 3,3-Difenil-allil-amin-származékok és eljárás előállításukra | |
SE9702799D0 (sv) | New compounds | |
JOP20190239A1 (ar) | مركبات مثبطة لـ vmat2 وتركيبات منها | |
HUP9700992A2 (hu) | 3-(Piperid-4-il)-1,2-benzizoxazol- és 3-(piperazin-4-il)-1,2-benzizoxazol-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítmények | |
NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
AR041395A1 (es) | Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla | |
SE9703377D0 (sv) | New compounds | |
DE3876813D1 (de) | 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. | |
AR041246A1 (es) | Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene | |
HUP0300857A2 (hu) | Peroxiszóma proliferátor aktivált agonisták | |
HUP0201357A2 (hu) | Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával | |
HUP0004588A2 (hu) | Szubsztituált 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-ol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerként, valamint a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0303361A2 (hu) | Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ES442119A1 (es) | Procedimiento para la preparacion de compuestos tetracicli- cos sustituidos en el grupo amino. | |
HUT43787A (en) | Process for production of medical compounds decreasing blood-pressure | |
HUP0301258A2 (hu) | Aminoizokinolincsoportot tartalmazó trombin inhibitorok és alkalmazásuk gyógyszerkészítmények előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |